Dual Antiplatelet Therapy Management During Acute Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Real-World Nationwide Analysis

被引:0
|
作者
Pu, Yuan [1 ]
Nanna, Michael [1 ]
Shung, Dennis [1 ]
Li, Darrick [1 ]
机构
[1] Yale Sch Med, New Haven, CT USA
来源
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词
D O I
10.14309/01.ajg.0001033188.81092.72
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S955
引用
收藏
页码:S663 / S663
页数:1
相关论文
共 50 条
  • [1] ACUTE GASTROINTESTINAL BLEEDING AMONG PATIENTS ON ANTIPLATELET AND ANTICOAGULANT THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
    Sveinsdottir, Asdis
    Gudmundsdottir, Ingibjorg
    Hreinsson, Johann P.
    Andersen, Karl
    Bjornsson, Einar
    GASTROENTEROLOGY, 2018, 154 (06) : S698 - S698
  • [2] Acute gastrointestinal bleeding among patients on antiplatelet and anticoagulant therapy after percutaneous coronary intervention
    Sveinsdottir, Asdis
    Gudmundsdottir, Ingibjorg J.
    Hreinsson, Johann P.
    Andersen, Karl
    Bjornsson, Einar S.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (06) : 733 - 739
  • [3] Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention
    Tan, Victoria P.
    Yan, Bryan P.
    Kiernan, Thomas J.
    Ajani, Andrew E.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2009, 10 (01) : 36 - 44
  • [4] Analysis of risk factors for gastrointestinal bleeding in percutaneous coronary intervention patients treated with dual antiplatelet therapy after surgery
    Chen, Caiping
    Fan, Huimin
    Shuai, Renya
    MEDICINE, 2025, 104 (14)
  • [5] REAL-WORLD EFFICACY AND SAFETY OF DUAL ANTIPLATELET THERAPY WITH TICAGRELOR AS COMPARED TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
    Wiens, Evan
    Leon, Silvia J.
    Whitlock, Reid
    Tangri, Navdeep
    Shah, Ashish
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1032 - 1032
  • [6] Acute gastrointestinal bleeding after percutaneous coronary intervention
    Wallace, Michael C.
    Rankin, Jamie
    Forbes, Geoffrey M.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (02) : 211 - 221
  • [7] Effect of de-escalated switching dual antiplatelet therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: real-world data from a nationwide cohort study
    Hsu, C. -Y.
    Yeh, J. -S.
    Huang, C. -Y.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1221 - 1221
  • [8] Bleeding versus ischemic risk during dual antiplatelet therapy on patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Nau, Gerardo
    Lalor, Nicolas
    Pedernera, Gustavo
    Daquarti, Gustavo
    Spaletra, Pablo
    Candiello, Alfonsina
    Padilla, Lucio
    Trivi, Marcelo
    Cura, Fernando
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2016, 45 (02): : 67 - 72
  • [9] In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry
    Yashima, Fumiaki
    Inohara, Taku
    Nishida, Hiroaki
    Shimoji, Kenichiro
    Ueno, Koji
    Noma, Shigetaka
    Yamaji, Kyohei
    Ishii, Hideki
    Tanaka, Nobuhiro
    Kohsaka, Shun
    Amano, Tetsuya
    Ikari, Yuji
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (02) : 221 - 227
  • [10] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 133 (21) : 2094 - 2098